Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CIPROFLOXACIN Cause Enterococcal infection? 64 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Enterococcal infection have been filed in association with CIPROFLOXACIN (Ciprofloxacin). This represents 0.2% of all adverse event reports for CIPROFLOXACIN.

64
Reports of Enterococcal infection with CIPROFLOXACIN
0.2%
of all CIPROFLOXACIN reports
31
Deaths
48
Hospitalizations

How Dangerous Is Enterococcal infection From CIPROFLOXACIN?

Of the 64 reports, 31 (48.4%) resulted in death, 48 (75.0%) required hospitalization, and 18 (28.1%) were considered life-threatening.

Is Enterococcal infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CIPROFLOXACIN. However, 64 reports have been filed with the FAERS database.

What Other Side Effects Does CIPROFLOXACIN Cause?

Drug hypersensitivity (5,266) Arthralgia (3,749) Pain (3,201) Fatigue (3,056) Drug ineffective (2,918) Nausea (2,689) Neuropathy peripheral (2,607) Diarrhoea (2,599) Pain in extremity (2,522) Dyspnoea (2,340)

What Other Drugs Cause Enterococcal infection?

TACROLIMUS (733) METHYLPREDNISOLONE (500) MYCOPHENOLATE MOFETIL (460) PREDNISONE (434) CYCLOPHOSPHAMIDE (407) RITUXIMAB (357) PREDNISOLONE (299) CYCLOSPORINE (293) METHOTREXATE (264) DEXAMETHASONE (260)

Which CIPROFLOXACIN Alternatives Have Lower Enterococcal infection Risk?

CIPROFLOXACIN vs CIPROFLOXACIN\DEXAMETHASONE CIPROFLOXACIN vs CIPROFLOXACIN\FLUOCINOLONE ACETONIDE CIPROFLOXACIN vs CISAPRIDE CIPROFLOXACIN vs CISATRACURIUM CIPROFLOXACIN vs CISPLATIN

Related Pages

CIPROFLOXACIN Full Profile All Enterococcal infection Reports All Drugs Causing Enterococcal infection CIPROFLOXACIN Demographics